These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11184657)

  • 1. Managed care issues in the treatment of gastroesophageal reflux disease.
    DeVault KR
    Am J Manag Care; 2000 Oct; 6(16 Suppl):S871-5. PubMed ID: 11184657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
    Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
    Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
    Morreale A
    Manag Care Interface; 2001; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion.
    Danzig J; Navarro R; Inami D; Morreale A; Tokayer A; Wong W; Compton J; Page RN; Sweet FB
    Manag Care Interface; 2001; Suppl B():13-20; discussion 24-7, 31-3. PubMed ID: 11569294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-reflux surgery in patients with adequate response to proton pump inhibitors - is there an indication?].
    Horstmann R; Gregor N; Classen C; Röttgermann S; Palmes D
    Z Gastroenterol; 2006 Dec; 44(12):1217-22. PubMed ID: 17163371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of immediate-release PPI therapy in the management of GERD and upper GI bleeding. Introduction.
    Peura DA
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():1. PubMed ID: 16303030
    [No Abstract]   [Full Text] [Related]  

  • 11. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
    Arguedas MR; Heudebert GR; Klapow JC; Centor RM; Eloubeidi MA; Wilcox CM; Spechler SJ;
    Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
    Johnson DA; Katz PO
    Rev Gastroenterol Disord; 2008; 8(2):98-108. PubMed ID: 18641592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
    Moayyedi P
    Digestion; 2008; 78 Suppl 1():61-9. PubMed ID: 18832842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do heartburn sufferers expect from proton pump inhibitors when prescribed for the first time?
    Kamolz T; Pointner R
    Minerva Gastroenterol Dietol; 2004 Jun; 50(2):143-7. PubMed ID: 15722984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroesophageal reflux disease.
    Rochman MV; Prescott J; Cave DG
    Manag Care Interface; 1999 Apr; 12(4):65-7. PubMed ID: 10387394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines.
    Fennerty MB; Castell D; Fendrick AM; Halpern M; Johnson D; Kahrilas PJ; Leiberman D; Richter JE; Sampliner RE
    Arch Intern Med; 1996 Mar; 156(5):477-84. PubMed ID: 8604953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of gastroesophageal reflux disease in a managed care environment. Based on a presentation by Kevin Ashby, MD.
    Am J Manag Care; 2000 May; 6(9 Suppl):S480-3. PubMed ID: 10977488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.